Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

A Phase I Trial of Total Marrow and Lymphoid Irradiation (TMLI)-Based Transplant Conditioning in Patients (Pts) with Relapsed/Refractory Acute Leukemia

Anthony Selwyn Stein, MD, Jeffrey Y. C. Wong, MD, Joycelynne Palmer, PhD, Margaret O'Donnell, MD, David S. Snyder, MD, Ni-Chun Tsai, Biostatition, Pablo Miguel Parker, MD, Ricardo Spielberger, MD, Len Farol, MD, Guido Marcucci, MD, Eric Radany, MD, Tim Schultheiss, MD, An Liu, MD, Ibrahim Aldoss, MD, Stephen J. Forman, MD

Blood (2015) 126 (23): 735.

https://doi.org/10.1182/blood.V126.23.735.735

Published: 2015

Journal Articles

Total Marrow Irradiation (TMI): A New Ablative Regimen as Part of Tandem (T) Autologous Peripheral Blood Progenitor Cell Transplant (AT) for Patients (pts) with Multiple Myeloma (MM).

George Somlo, M.D., F.A.C.P., Ricardo Spielberger, MD, Paul Frankel, Chatchada Karanes, MD, Amrita Krishnan, MD, FACP, Pablo Miguel Parker, MD, Leslie Popplewell, Firoozeh Sahebi, Tim Schultheiss, Neil Martin Kogut, MD, An Liu, David S. Snyder, MD, Stephen J. Forman, Jeffrey Y. Wong

Blood (2008) 112 (11): 3326.

https://doi.org/10.1182/blood.V112.11.3326.3326

Published: 2008

Journal Articles

Membranous Glomerulonephritis and Nephrotic Syndrome as a Late Manifestation of Chronic Graft-Versus-Host Reaction Following Allogeneic Transplantation for Hematologic Malignancy.

Bashir Ahmad, MD, Barbara Stehr, NP, Laura Johnston, MD, Eileen Patricia Smith, MD, Auayporn P. Nademanee, MD, Pablo Miguel Parker, MD, Robert Negrin, MD, Stephen J. Forman, MD

Blood (2006) 108 (11): 2894.

https://doi.org/10.1182/blood.V108.11.2894.2894

Published: 2006

Journal Articles

The Use of Sirolimus Combined with Tacrolimus and Low-Dose Methotrexate Is Effective in Preventing Graft-Versus-Host Disease after Unrelated Donor Hematopoietic Stem Cell Transplantation.

Ryotaro Nakamura, MD, Roberto Rodriguez, MD, Auayporn Nademanee, MD, Joycelynne Palmer, PhD, David Senitzer, PhD, David Snyder, MD, Jasmine Zain, MD, Vinod Pullarkat, MD, Stephen J. Forman, MD, Pablo Miguel Parker, MD

Blood (2006) 108 (11): 2866.

https://doi.org/10.1182/blood.V108.11.2866.2866

Published: 2006

Journal Articles

Tacrolimus and Sirolimus as GVHD Prophylaxis for HLA-MRD Allogeneic HCT Conditioned with 3 Regimens: Toxicity and Efficacy in 70 Patients.

Roberto Rodriguez, MD, Joycelynne Palmer, PhD, Ryotaro Nakamura, MD, Pablo Miguel Parker, MD, Auayporn P. Nademanee, MD, David S. Snyder, MD, Vinod Pullarkat, MD, Jasmine M. Zain, MD, Ricardo Spielberger, MD, David Senitzer, PhD, Stephen J. Forman, MD

Blood (2006) 108 (11): 2867.

https://doi.org/10.1182/blood.V108.11.2867.2867

Published: 2006

Journal Articles

Tandem Cycle High-Dose Melphalan and Busulfan/Cyclophosphamide Followed by Maintenance Interferon Alpha-2 (IF) with or without Thalidomide (Thal) Is Associated with High Complete and Very Good Partial Response Rates, Improved Progression-Free, and Overall Survival.

George Somlo, MD, Dajun Qian, PhD, Firoozeh Sahebi, MD, Neil Martin Kogut, MD, Roberto Rodriguez, MD, Pablo Miguel Parker, MD, Leslie Popplewell, MD, Amrita Krishnan, MD, Joycelynne Palmer, PhD, Anthony Selwyn Stein, MD, Ricardo Spielberger, MD, Jeffrey Schriber, MD, Joseph Alvarnas, MD, Warren Chow, MD, Auayporn Nademanee, MD, Jasmine M. Zain, MD, Margaret R. O’Donnell, MD, Stephen J. Forman, MD

Blood (2006) 108 (11): 3089.

https://doi.org/10.1182/blood.V108.11.3089.3089

Published: 2006

Journal Articles

Use of Fluid-Ventilated, Gas-Permeable Scleral Lens (SL) for Management of Severe Keratoconjunctivitis Sicca Secondary to Chronic Graft-Versus-Host Disease.

Kikuchi Takahide, MD, Pablo Miguel Parker, MD, Michael Wu, MD, Paul A. Carpenter, MD, Barbara Stehr, ARNP, Perry Rosenthal, MD, Paul J. Martin, MD, Stephen J. Forman, MD, Mary E.D. Flowers, MD

Blood (2006) 108 (11): 2913.

https://doi.org/10.1182/blood.V108.11.2913.2913

Published: 2006

NARROW

A Phase I Trial of Total Marrow and Lymphoid Irradiation (TMLI)-Based Transplant Conditioning in Patients (Pts) with Relapsed/Refractory Acute Leukemia

Total Marrow Irradiation (TMI): A New Ablative Regimen as Part of Tandem (T) Autologous Peripheral Blood Progenitor Cell Transplant (AT) for Patients (pts) with Multiple Myeloma (MM).

Membranous Glomerulonephritis and Nephrotic Syndrome as a Late Manifestation of Chronic Graft-Versus-Host Reaction Following Allogeneic Transplantation for Hematologic Malignancy.

The Use of Sirolimus Combined with Tacrolimus and Low-Dose Methotrexate Is Effective in Preventing Graft-Versus-Host Disease after Unrelated Donor Hematopoietic Stem Cell Transplantation.

Tacrolimus and Sirolimus as GVHD Prophylaxis for HLA-MRD Allogeneic HCT Conditioned with 3 Regimens: Toxicity and Efficacy in 70 Patients.

Tandem Cycle High-Dose Melphalan and Busulfan/Cyclophosphamide Followed by Maintenance Interferon Alpha-2 (IF) with or without Thalidomide (Thal) Is Associated with High Complete and Very Good Partial Response Rates, Improved Progression-Free, and Overall Survival.

Use of Fluid-Ventilated, Gas-Permeable Scleral Lens (SL) for Management of Severe Keratoconjunctivitis Sicca Secondary to Chronic Graft-Versus-Host Disease.

Email alerts

ASH Publications

American Society of Hematology

A Phase I Trial of Total Marrow and Lymphoid Irradiation (TMLI)-Based Transplant Conditioning in Patients (Pts) with Relapsed/Refractory Acute Leukemia

Total Marrow Irradiation (TMI): A New Ablative Regimen as Part of Tandem (T) Autologous Peripheral Blood Progenitor Cell Transplant (AT) for Patients (pts) with Multiple Myeloma (MM).

Membranous Glomerulonephritis and Nephrotic Syndrome as a Late Manifestation of Chronic Graft-Versus-Host Reaction Following Allogeneic Transplantation for Hematologic Malignancy.

The Use of Sirolimus Combined with Tacrolimus and Low-Dose Methotrexate Is Effective in Preventing Graft-Versus-Host Disease after Unrelated Donor Hematopoietic Stem Cell Transplantation.

Tacrolimus and Sirolimus as GVHD Prophylaxis for HLA-MRD Allogeneic HCT Conditioned with 3 Regimens: Toxicity and Efficacy in 70 Patients.

Tandem Cycle High-Dose Melphalan and Busulfan/Cyclophosphamide Followed by Maintenance Interferon Alpha-2 (IF) with or without Thalidomide (Thal) Is Associated with High Complete and Very Good Partial Response Rates, Improved Progression-Free, and Overall Survival.

Use of Fluid-Ventilated, Gas-Permeable Scleral Lens (SL) for Management of Severe Keratoconjunctivitis Sicca Secondary to Chronic Graft-Versus-Host Disease.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only